Literature DB >> 24414488

AIDS in Africa: distinguishing fact and fiction.

E Papadopulos-Eleopulos1, V F Turner, J M Papadimitriou, H Bialy.   

Abstract

The data widely purporting to show the existence and heterosexual transmission in Africa of a new syndrome caused by a retrovirus which induces immune deficiency are critically evaluated. It is concluded that both acquired immune deficiency (AID) and the symptoms and diseases which constitute the clinical syndrome (S) are of long standing in Africa, affect both sexes equally and are caused directly and indirectly by factors other than human immunodeficiency virus (HIV). Seropositivity to HIV in Africans usually represents no more than cross-reactivity caused by an abundance of antibodies induced by the numerous infectious and parasitic diseases which are endemic in Africa. The apparently high prevalence of 'AIDS' and 'HIV' seropositives is therefore not surprising and is not proof of heterosexual transmission of either HIV or AIDS.

Entities:  

Year:  1995        PMID: 24414488     DOI: 10.1007/BF00704634

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  40 in total

1.  Heterosexual transmission of AIDS.

Authors:  R B Pearce
Journal:  JAMA       Date:  1986-08-01       Impact factor: 56.272

2.  AIDS in Africa: an epidemiologic paradigm.

Authors:  T C Quinn; J M Mann; J W Curran; P Piot
Journal:  Science       Date:  1986-11-21       Impact factor: 47.728

3.  HIV testing is the answer--what's the question?

Authors:  R Weiss; S O Thier
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

4.  Female-to-male transmission of AIDS: a reexamination of the African sex ratio of cases.

Authors:  N Padian; J Pickering
Journal:  JAMA       Date:  1986-08-01       Impact factor: 56.272

5.  Slim disease: a new disease in Uganda and its association with HTLV-III infection.

Authors:  D Serwadda; R D Mugerwa; N K Sewankambo; A Lwegaba; J W Carswell; G B Kirya; A C Bayley; R G Downing; R S Tedder; S A Clayden; R A Weiss; A G Dalgleish
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

6.  Which anti-HTLV III/LAV assays for screening and confirmatory testing?

Authors:  P P Mortimer; J V Parry; J Y Mortimer
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

7.  Surveillance for AIDS in a central African city. Kinshasa, Zaire.

Authors:  J M Mann; H Francis; T Quinn; P K Asila; N Bosenge; N Nzilambi; K Bila; M Tamfum; K Ruti; P Piot
Journal:  JAMA       Date:  1986-06-20       Impact factor: 56.272

8.  Acquired immunodeficiency syndrome in a heterosexual population in Zaire.

Authors:  P Piot; T C Quinn; H Taelman; F M Feinsod; K B Minlangu; O Wobin; N Mbendi; P Mazebo; K Ndangi; W Stevens
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

9.  Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study.

Authors:  L A Kingsley; R Detels; R Kaslow; B F Polk; C R Rinaldo; J Chmiel; K Detre; S F Kelsey; N Odaka; D Ostrow
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

10.  Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection.

Authors:  T C Quinn; P Piot; J B McCormick; F M Feinsod; H Taelman; B Kapita; W Stevens; A S Fauci
Journal:  JAMA       Date:  1987-05-15       Impact factor: 56.272

View more
  1 in total

Review 1.  Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome.

Authors:  Yan-Mei Huang; Xue-Zhi Hong; Jia-Hua Xu; Jiang-Xi Luo; Han-You Mo; Hai-Lu Zhao
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.